Satish Gopal, M.D., M.P.H.
Satish Gopal, M.D., M.P.H., was appointed Director of the National Cancer Institute’s (NCI) Center for Global Health (CGH) in 2020. In 2025, he assumed additional responsibilities as Special Advisor to the NCI Director and, in 2026, as Acting NCI Deputy Director for Scientific Strategy and Development.
Dr. Gopal earned his medical degree from the Duke University School of Medicine. He completed training in internal medicine and pediatrics at the University of Michigan, lived and worked in Tanzania from 2007 to 2009, then returned to the United States to pursue medical oncology and infectious disease training at the University of North Carolina (UNC). He subsequently joined the faculty of the UNC Lineberger Comprehensive Cancer Center. From 2012 to 2020, he and his family primarily lived and worked in Malawi, where he was the country’s only medical oncologist and treated public-sector cancer patients at the national teaching hospital. He returned frequently to provide clinical service at the North Carolina Cancer Hospital.
As an extramural physician-scientist, his NIH-funded research program focused on epidemiologic, clinical, and translational studies of lymphoid and HIV-associated malignancies in Africa. He also oversaw a multidisciplinary cancer research portfolio addressing many of the region’s most common cancers, including cervical, breast, and esophageal cancer. This program generated some of the first published studies in Africa to describe detailed molecular profiles for specific cancer types, characterize several unique lymphoproliferative disorders, report clinical trials of targeted cancer therapy, perform economic evaluations of cancer treatment, and integrate patient-reported outcome measurements. He has mentored many early-career cancer researchers, many of whom now hold academic positions in global oncology at NCI-designated cancer centers, African academic institutions, and other international organizations. As an adjunct intramural investigator at the NCI, Dr. Gopal continues clinical and translational research related to lymphoid malignancies in Africa. He previously served as the Associate Chair for African International Sites for the NCI AIDS Malignancy Consortium (AMC) with oversight responsibility for the network’s African clinical trials. He currently serves as the US representative on the Scientific Council for the International Agency for Research on Cancer (IARC), as an Ex Officio Advisory Board Member for the NIH Fogarty International Center, and as an Advisory Board Member for the Institute of Cancer Research of the Canadian Institutes of Health Research. Dr. Gopal is a recipient of the 2024 American Society of Clinical Oncology Humanitarian Award.